Guggenheim Capital’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-214
| Closed | -$4K | – | 2132 |
|
|
2022
Q1 | $4K | Buy |
+214
| New | +$4K | ﹤0.01% | 2112 |
|
|
2019
Q2 | – | Sell |
-12,535
| Closed | -$3.05M | – | 2178 |
|
|
2019
Q1 | $3.05M | Hold |
12,535
| – | – | 0.02% | 881 |
|
|
2018
Q4 | $2.39M | Buy |
12,535
+6,049
| +93% | +$1.15M | 0.02% | 946 |
|
|
2018
Q3 | $2.13M | Buy |
+6,486
| New | +$2.13M | 0.01% | 1200 |
|
|
2018
Q2 | – | Sell |
-828
| Closed | -$201K | – | 2601 |
|
|
2018
Q1 | $201K | Sell |
828
-636
| -43% | -$154K | ﹤0.01% | 2616 |
|
|
2017
Q4 | $441K | Sell |
1,464
-63
| -4% | -$19K | ﹤0.01% | 2398 |
|
|
2017
Q3 | $404K | Sell |
1,527
-125
| -8% | -$33.1K | ﹤0.01% | 2461 |
|
|
2017
Q2 | $435K | Buy |
1,652
+269
| +19% | +$70.8K | ﹤0.01% | 2445 |
|
|
2017
Q1 | $498K | Buy |
1,383
+657
| +90% | +$237K | ﹤0.01% | 2380 |
|
|
2016
Q4 | $209K | Buy |
726
+418
| +136% | +$120K | ﹤0.01% | 2681 |
|
|
2016
Q3 | $105K | Buy |
308
+78
| +34% | +$26.6K | ﹤0.01% | 2723 |
|
|
2016
Q2 | $98K | Buy |
+230
| New | +$98K | ﹤0.01% | 2729 |
|
|
2015
Q2 | – | Sell |
-214
| Closed | -$65K | – | 3097 |
|
|
2015
Q1 | $65K | Buy |
+214
| New | +$65K | ﹤0.01% | 2897 |
|
|
2014
Q1 | – | Sell |
-728
| Closed | -$190K | – | 3277 |
|
|
2013
Q4 | $190K | Buy |
728
+434
| +148% | +$113K | ﹤0.01% | 2799 |
|
|
2013
Q3 | $43K | Buy |
+294
| New | +$43K | ﹤0.01% | 2890 |
|